Gilead Sciences Inc.

09/16/2021 | Press release | Distributed by Public on 09/16/2021 05:06

Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple-Negative Breast Cancer in Phase 3 ASCENT Study